Squarepoint’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
+3,900
New +$330K ﹤0.01% 3917
2025
Q4
– Sell
-5,700
Closed -$640K – 4894
2025
Q3
$640K Buy
5,700
+1,000
+21% +$117K ﹤0.01% 3036
2025
Q2
$630K Sell
4,700
-2,300
-33% -$253K ﹤0.01% 3074
2025
Q1
$471K Buy
+7,000
New +$481K ﹤0.01% 3361

Other funds holding TMDX

Squarepoint's TMDX Position: Q2 2026 in Review

Squarepoint sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 7,274 shares — an estimated $616K sold.

Squarepoint first reported a position in TMDX in Q2 2019 and held it in 23 quarters. The position peaked at $35.6M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Squarepoint reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Squarepoint sold 7,274 Transmedics shares in Q2 2026, an estimated $616K.
  • Squarepoint first reported a position in Transmedics in Q2 2019 and held it in 23 quarters.
  • Squarepoint's Transmedics position peaked at $35.6M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.